Worldwide oesophageal cancer collaboration guidelines for lymphadenectomy predict survival following neoadjuvant therapy

European Journal of Cardio-thoracic Surgery

Volumn 42, Issue 4, 2012, Pages 659-664

  Stiles, Brendon M ^a   Nasar, Abu ^a   Mirza, Farooq A ^a   Lee, Paul C ^a   Paul, Subroto ^a   Port, Jeffrey L ^a   Altorki, Nasser K ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Lymphadenectomy; Neoadjuvant therapy; Oesophageal cancer

Indexed keywords

CAPECITABINE; EPIRUBICIN; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; COHORT ANALYSIS; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL PREDICTION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84873125767     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezs105     Document Type: Article

References (13)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. DeMeester SR. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol 2006;13:12-30.
3. Kang CH, Kim YT, Jeon SH, Sung SW, Kim JH. Lymphadenectomy extent is closely related to long-term survival in esophageal cancer. Eur J Cardiothorac Surg 2007;31:154-60.
4. Altorki NK, Zhou XK, Stiles B, Port JL, Paul S, Lee PC et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg 2008;248:221-6.
5. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer 2008;112:1239-46.
6. Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastrointest Surg 2007;11:1384-93; discussion 1393-4.
7. Peyre CG, Hagen JA, DeMeester SR, Altorki NK, Ancona E, Griffin SM et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 2008;248:549-56.
8. Rizk NP, Ishwaran H, Rice TW, Chen LQ, Schipper PH, Kesler KA et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg 2010;251: 46-50.
9. Lee PC, Mirza FM, Port JL, Stiles BM, Paul S, Christos P et al. Predictors of recurrence and disease-free survival in patients with completely resected esophageal carcinoma. J Thorac Cardiovasc Surg 2011;141: 1196-206.
10. Rizzetto C, DeMeester SR, Hagen JA, Peyre CG, Lipham JC, DeMeester TR. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma. J Thorac Cardiovasc Surg 2008;135:1228-36.
11. Nigro JJ, DeMeester SR, Hagen JA, DeMeester TR, Peters JH, Kiyabu M et al. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg 1999; 117:960-8.
12. Rice TW, Zuccaro G Jr, Adelstein DJ, Rybicki LA, Blackstone EH, Goldblum JR. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg 1998;65:787-92.
13. Stiles BM, Christos P, Port JL, Lee PC, Paul S, Saunders J et al. Predictors of survival in patients with persistent nodal metastases after preoperative chemotherapy for esophageal cancer. J Thorac Cardiovasc Surg 2010; 139:387-94.